Cong Sun

Title: Cong Sun - Innovator in Nanoparticle Technology

Introduction

Cong Sun is a prominent inventor based in Guangdong, China. He has made significant contributions to the field of nanoparticle technology, particularly in relation to the Epstein-Barr virus (EBV). His innovative work has led to the development of a unique self-assembled nanoparticle that has potential applications in medical research and treatment.

Latest Patents

Cong Sun holds a patent for a self-assembled nanoparticle containing the gB protein of the EB virus. The patent describes a preparation method and the use of this nanoparticle. The self-assembled nanoparticle comprises a first polypeptide, which includes the gB protein and a first vector subunit, and a second polypeptide that contains a second vector subunit. Notably, the gB protein of the EB virus is displayed on the surface of the nanoparticle for the first time. This innovation results in a particle size larger than that of the antigen gB, with enhanced chemical stability and improved binding capacity with neutralizing antibodies compared to the antigen gB. Cong Sun's work in this area has the potential to advance the understanding and treatment of EBV-related diseases.

Career Highlights

Cong Sun has worked at notable institutions, including Sun Yat-sen University and the Sun Yat-sen University Cancer Center. His experience in these prestigious organizations has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Some of Cong Sun's notable coworkers include Xinchun Chen and Yinfeng Kang. Their collaborative efforts have furthered research in nanoparticle technology and its applications in medicine.

Conclusion

Cong Sun's innovative work in developing self-assembled nanoparticles represents a significant advancement in the field of medical research. His contributions have the potential to impact the treatment of diseases associated with the Epstein-Barr virus.